Featured Speakers

• 

  Napoleone FerraraDistinguished Professor UC San Diego

• 

  Anderson ClarkDirector of in vivo Pharmacology EMD Serono

• 

  Frank GibbonsPrincipal Scientist AstraZeneca

• 

  George NaumovSenior Research Biologist Merck

Better Preclinical Models. Better Predictions. Better Patient Response.

Tumor Models gives you the tools to develop and utilize the very best preclinical oncology models. 

This is a meeting for drug developers who are looking for answers to the difficulties faced with preclinical oncology models that are currently being used to test new cancer drugs. This is a forum to learn what you really need to know about the models pharma are using that are superior in predicting efficacy and mimicking tumor activity in patients. It’s also the best way to identify what preclinical questions need to be answered and make the best possible translational decisions. Decisions that will lead to more effective drug performance in the clinic. 

Build confidence in the candidates you nominate for pipeline progression

Tumor Models will arm you with everything you need to know to ensure that your tumor models are as predictive of clinical outcome as possible. Whether you’re looking to build more humanized models to ensure more predictive results, or looking to interpret the data from existing technology to make better decisions, this agenda has been designed to cure your headaches.

Never before has such a breadth of drug developers and world renowned academics been brought together to address the issues associated with Tumor Models. Listen to Napoleone Ferrara and Terri Van Dyke as they share their world respected views on how to address the current rate of attrition using tumor models. 16 distinct drug developers will be sharing their secrets to the models they use and the data generated for translational decision making. Learn from them. Ask them questions. Expand your list of contacts. 

Download the brochure for more information 

Why attend Tumor Models? 

• Understand how leading drug developers are using preclinical tumor models that are superior in predicting clinical efficacy
• Understand how to integrate novel tumor models into your existing protocols and build confidence in selected molecules
• Better apply and interpret tumor models to ensure their relevance to clinical tumor subtypes

Attendees will leave armed with a list of practical ideas to optimize their current tumor models. Meet and network with cancer researchers, academics and drug developers to ensure maximum quality of discussions and add valuable contacts to your network. 

This means that it is for:

• Drug developers who are looking to optimize current tumor models and explore practical alternatives to ensure the effective translation of preclinical data into a clinical setting
• Small biotechs and model providers looking to showcase their optimized and alternative tumor model platforms
• Academics and researchers looking to learn more about the most up to date tumor models, together with alternate animal systems. It’s also a great opportunity to look for collaborations and funding
• CRO’s specializing in preclinical drug development and oncology

Download Brochure | Agenda | Packages & Prices | Register